Showing 1 - 6 results out of 6
Sort By
List View
Card View
Single-cell Genomic Approaches for Developing the Next Generation of Immunotherapies
Developments in single-cell genomics, proteomics, computing, and antibody engineering have enabled significant progress in drug development. See how and read now.
BD Joins Consortium to Accelerate Technology Development and Lower the Costs in Cell and Gene Therapy Manufacturing
Wouldn’t it be wonderful if we could reach a point in medical history where disease can be cured without drugs? A step in that direction has been taken this year by BD, which has joined a consortium of over 20 companies with the aim of pooling knowledge in cell and gene therapy.
Bifidobacteria-Mediated Immune System Imprinting Early In Life
The lack of bifidobacteri, is associated with systemic inflammation and immune dysregulation in early life.
Antigen-specific B cells and chronic infection: The OMIP panel
Originating in the bone marrow, antigen-specific B cells are critical in infection prevention and control through antibody production, professional antigen presentation and cytokine secretion.
Immunotyping of Natural Killer (NK) Cells in COVID-19 Patients Using High-Parameter Flow Cytometry
SARS-CoV-2 infection elicits a spectrum of immune responses, activating both the innate and adaptive immune systems. Whether these immune responses are targeted and controlled or misdirected and uncontrolled could determine the outcome of the disease.
High-Parameter Flow Cytometry for Deep Immune Profiling of COVID-19 Patients
The SARS-CoV-2 virus infection presents a range of clinical manifestations, ranging from mild or no symptoms to moderate to severe respiratory illnesses, such as ARDS (acute respiratory-distress syndrome) and multiorgan failure, to death.